中国心血管病风险评估和管理指南.PDF

4 中国循环杂志 2019 年 1 月 第 34 卷 第 1 期（总第 247 期）Chinese Circulation Journal，January，2019，Vol. 34 No.1（Serial No.247） 指南与共识 中国心血管病风险评估和管理指南 中国心血管病风险评估和管理指南编写联合委员会 摘要 心血管病是造成我国居民死亡和疾病负担的首要病因，心血管病防控形势严峻。心血管病风险评估和危险因素 管理是预防心血管病的重要基础。根据国内外最新的流行病学和防治证据，本指南着重介绍了我国开展心血管病风 险评估的指导方案，包括心血管病 10 年风险和终生风险评估的流程，风险分层依据和风险评估工具的使用。针对心 血管病的一级预防，本指南进一步介绍了生活方式干预的基本措施，血压、血脂、血糖管理的基本原则等内容。本 指南的实施有助于指导我国心血管病风险评估和相关危险因素管理，推进基层心血管病预防工作。 关键词 心血管疾病； 危险性评估； 一级预防； 指南 Guideline on the Assessment and Management of Cardiovascular Risk in China The Joint Task Force for Guideline on the Assessment and Management of Cardiovascular Risk in China Corresponding Author: GU Dongfeng, Email: gudongfeng@vip. sina. com Abstract Cardiovascular disease (CVD) is the leading cause of death and burden of diseases in China. Prevention and control of CVD has been challenging. Risk assessment and management for CVD risk factors are essential for primary prevention of CVD. According to recent observational and interventional evidences worldwide and studies in Chinese population, the guideline introduced how to conduct cardiovascular risk assessment in China, including the procedure for 10⁃year and lifetime risk assessment, the risk stratification, and the application of web⁃based and mobile risk assessment tools. Furthermore, in order to facilitate the primary prevention of CVD, the guideline targeted therapeutic lifestyle changes, and highlighted principles for management of blood pressure, lipids, and glucose, etc. The implementation of the guideline will facilitate the risk assessment of CVD and risk factor management, and promote both individualized and community⁃based prevention of CVD in China. Key words cardiovascular diseases; risk assessment; primary prevention; guideline (Chin